Identity
- Trade Name
- reSET-O® FDA UDI
- Generic Name
- Psychological assessment software FDA UDI
- Device Name
- reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system. FDA UDI
- Model / Reference
- 1 FDA UDI
- Description
- reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system. FDA UDI
Identifiers
- Catalog Number
- N/A FDA UDI
- Primary DI / UDI-DI
- 10196439000029 FDA UDI
- 510(k) Number
- K173681 FDA UDI
- FDA Product Code
- PWE FDA UDI
- GMDN Term
- Psychological assessment software FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 882.5801 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Psychological assessment software
reSET-O® by Pear Therapeutics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Psychological assessment software.
- CNS Vital Signs Cognitrax — CNS VITAL SIGNS · Class II
- ANAM Test System: Military, Military Expanded, Core, Core Expanded, and Sports — VISTA PARTNERS, LLC · Class II
- CNS Vital Signs VSC — CNS VITAL SIGNS · Class II
- ANAM Test System — VISTA PARTNERS, LLC · Class II
- QbTest — Qbtech Inc · U
- CNS Vital Signs Local — CNS VITAL SIGNS · Class II
- ANAM Test System: Military Battery — VISTA PARTNERS, LLC · Class II
- CNS Vital Signs Web — CNS VITAL SIGNS · Class II
Cleared under the same submission
K173681 also covers:
- PursueCare RESET-O — HARVEST BIO LLC
- PursueCare RESET-O — HARVEST BIO LLC
- reSET-O® — Pear Therapeutics, Inc.
- reSET-O® Demo Version — Pear Therapeutics, Inc.
- reSET-O® Demo Version (Mobile App, Android) — Pear Therapeutics, Inc.
- reSET-O® Demo Version (Mobile App, iOS) — Pear Therapeutics, Inc.
- reSET-O® Mobile App, Android — Pear Therapeutics, Inc.
- reSET-O® Mobile App, iOS — Pear Therapeutics, Inc.
- reSET-O® Non-Monetary CM — Pear Therapeutics, Inc.
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Pear Therapeutics, Inc.
Sources (1)
- FDA UDI 711ad631-d3b6-452a-b9e7-315b0f16eeb2 35 fields · synced Jun 8, 2026